Clinical Relevance of Targeting the Gastrin-Releasing Peptide Receptor, Somatostatin Receptor 2, or Chemokine C-X-C Motif Receptor 4 in Breast Cancer for Imaging and Therapy - Dalm, SU; Sieuwerts, AM; Look, MP (J Nucl Med, 2015)
et al.